Elizabeth Hermsen | Head, Global Antimicrobial Stewardship
Merck & Co., Inc.

Elizabeth Hermsen, Head, Global Antimicrobial Stewardship, Merck & Co., Inc.

Dr. Hermsen is the Head of Global Antimicrobial Stewardship in Global Population Health at Merck & Co. and an Adjunct Associate Professor at the University of Nebraska Medical Center, Colleges of Pharmacy and Medicine, in Omaha, Nebraska.  Dr. Hermsen received her Doctor of Pharmacy degree from the University of Nebraska Medical Center followed by a pharmacy practice residency at The Nebraska Medical Center and a fellowship in Infectious Diseases Research and master’s degree in business administration at the University of Minnesota.  Dr. Hermsen developed and co-directed the antimicrobial stewardship program at The Nebraska Medical Center and subsequently joined Cubist, where she created and led the Antimicrobial Stewardship Outreach Group.  Now, in her role at Merck, she is responsible for creating and executing a strategy to advance patient-centered antimicrobial stewardship through education, implementation, research, and advocacy.  
Dr. Hermsen has contributed to antimicrobial stewardship on a national level in a number of ways.  
When leading the program at The Nebraska Medical Center, she developed a publicly-available antimicrobial stewardship website (www.nebraskamed.com/asp) that subsequently was featured in an article regarding top web resources for antimicrobial stewardship (Pagani L, et al. Navigating the Web in Search of Resources on Antimicrobial Stewardship in Health Care Institutions. Clin Infect Dis. 2009; 48:626-32.) and is still available today.
During her tenure with Cubist, Dr. Hermsen created the Antimicrobial Stewardship Outreach Group, which led a variety of antimicrobial stewardship-related initiatives including development of an antimicrobial stewardship research grant program; a research collaborative for antimicrobial stewardship programs; quarterly virtual roundtables for antimicrobial stewardship personnel across the United States; PowerPoint presentations used for education regarding antimicrobial stewardship; a comprehensive bibliography of antimicrobial stewardship publications over the past 20+ years; and a supplement to Clinical Infectious Diseases regarding the need for patient-centered antimicrobial stewardship (http://cid.oxfordjournals.org/content/59/suppl_3.toc); among others.  Dr. Hermsen has also worked on various legislation/policy issues related to antimicrobial stewardship, including the Generating Antibiotic Incentives Now (GAIN) Act.
Dr. Hermsen actively contributed to the advancement of the Society of Infectious Diseases Pharmacists Antimicrobial Stewardship Certificate Program during her term as SIDP President and continues to participate as a lecturer in the program.  Dr. Hermsen served as a contributing member of the Antimicrobial Stewardship Knowledge & Skills Collaborative, coordinated by the Society for Healthcare Epidemiology of America; an expert panel on Antimicrobial Practice Improvement in Hospitals, coordinated by the American Society of Health-System Pharmacists (www.ashpadvantage.com/stewardship); an expert panel on Hospital-based Antimicrobial Utilization Surveillance via the National Healthcare Safety Network, coordinated by the Centers for Disease Control and Prevention (CDC); the Cardinal Health Infectious Diseases Advisory Group; an expert panel coordinated by the National Quality Forum and CDC to develop the practical tool entitled,  Antibiotic Stewardship in Acute Care: A Practical Playbook (http://www.qualityforum.org/Publications/2016/05/National_Quality_Partners_Playbook__Antibiotic_Stewardship_in_Acute_Care.aspx); and is Co-Chair of the Antimicrobial Stewardship Work Package for the Innovative Medicines Institute (IMI) Driving Reinvestment in Research & Development and Responsible Antibiotic Use (DRIVE-AB) initiative (www.drive-ab.eu).
She has further contributed to the field with over 100 publications, book contributions, and by serving as a reviewer for several professional journals.  Dr. Hermsen has also given a number of antimicrobial stewardship presentations at state, regional, national, and international meetings.


World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 12:15

Putting a one health approach to AMR into action at Merck

  • What does One Health mean and why is it important to AMR?
  • What are opportunities for One Health collaboration between human and animal health?
  • Are there any best practices for a One Health approach?
last published: 16/Oct/18 16:45 GMT

back to speakers